ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	996.28	957.8	726.44	517.24	484.15	441.76
Revenue Growth (YoY)	22.42%	31.85%	40.45%	6.83%	9.60%	30.28%
Cost of Revenue	401.12	385.09	393.26	371.74	258.56	286.88
Gross Profit	595.17	572.71	333.18	145.49	225.59	154.88
Selling, General & Admin	506.81	488.43	406.56	369.09	396.03	388.66
Operating Expenses	506.81	488.43	406.56	369.09	396.03	388.66
Operating Income	88.36	84.28	-73.38	-223.6	-170.44	-233.79
Interest & Investment Income	27.85	25.46	17.23	6.61	0.59	6.61
Other Non Operating Income (Expenses)	2.13	1.82	-	-	-	-
EBT Excluding Unusual Items	118.34	111.56	-56.15	-216.99	-169.85	-227.18
Merger & Restructuring Charges	-	-	-	-	-	-52.8
Gain (Loss) on Sale of Investments	-	-	5.11	3.54	2.33	-1
Gain (Loss) on Sale of Assets	146.52	146.52	-	-	-	-
Pretax Income	264.85	258.08	-51.04	-213.44	-167.52	-280.97
Income Tax Expense	35.97	31.62	10.25	2.53	0.35	0.61
Net Income	228.88	226.45	-61.29	-215.98	-167.87	-281.58
Net Income to Common	228.88	226.45	-61.29	-215.98	-167.87	-281.58
Shares Outstanding (Basic)	166	166	164	162	160	157
Shares Outstanding (Diluted)	167	166	164	162	160	157
Shares Change (YoY)	1.32%	1.55%	1.32%	0.74%	2.01%	6.88%
EPS (Basic)	1.38	1.37	-0.37	-1.34	-1.05	-1.79
EPS (Diluted)	1.37	1.36	-0.37	-1.34	-1.05	-1.79
Free Cash Flow	148.44	157.2	16.65	-114.04	-126.78	-143.75
Free Cash Flow Per Share	0.89	0.94	0.10	-0.70	-0.79	-0.91
Gross Margin	59.74%	59.79%	45.87%	28.13%	46.59%	35.06%
Operating Margin	8.87%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Profit Margin	22.97%	23.64%	-8.44%	-41.76%	-34.67%	-63.74%
Free Cash Flow Margin	14.90%	16.41%	2.29%	-22.05%	-26.19%	-32.54%
EBITDA	101.67	100.16	-67.83	-221.57	-167.1	-230.85
EBITDA Margin	10.20%	10.46%	-9.34%	-42.84%	-34.51%	-52.26%
D&A For EBITDA	13.31	15.88	5.55	2.03	3.34	2.93
EBIT	88.36	84.28	-73.38	-223.6	-170.44	-233.79
EBIT Margin	8.87%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Effective Tax Rate	13.58%	12.25%	-	-	-	-
Revenue as Reported	996.28	957.8	726.44	517.24	484.15	441.76
Advertising Expenses	-	21.1	9.4	5.5	41.8	51.1

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q